Marshall Wace’s Urovant Sciences Ltd. UROV Stock Holding History

Marshall Wace’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-34,494	Closed	-$556K	–	3068
2020 Q4	$556K	Buy	+34,494	New	+$428K	﹤0.01%	1421
2020 Q1	–	Sell	-5,324	Closed	-$83K	–	2248
2019 Q4	$83K	Buy	+5,324	New	+$57.7K	﹤0.01%	1483
2019 Q2	–	Sell	-32,329	Closed	-$325K	–	2034
2019 Q1	$325K	Buy	+32,329	New	+$331K	﹤0.01%	1243

Marshall Wace's UROV Position: Q1 2021 in Review

Marshall Wace sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 34,494 shares — an estimated $556K sold.

Marshall Wace first reported a position in UROV in Q1 2019 and held it in 3 quarters. The position peaked at $556K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Marshall Wace reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Marshall Wace sold 34,494 Urovant Sciences Ltd. shares in Q1 2021, an estimated $556K.
Marshall Wace first reported a position in Urovant Sciences Ltd. in Q1 2019 and held it in 3 quarters.
Marshall Wace's Urovant Sciences Ltd. position peaked at $556K in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.